Can Inflammation-Resolution Provide Clues to Treat Patients According to Their Plaque Phenotype?
Inflammation-resolution is an active process that is governed in part by specialized pro-resolving mediators (SPMs) such as lipoxins, resolvins, protectins, and maresins. SPMs, which are endogenously biosynthesized, quell inflammation and repair tissue damage in a manner that does not compromise hos...
Main Author: | Gabrielle Fredman |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00205/full |
Similar Items
-
Critical Role of Inflammation and Specialized Pro-Resolving Mediators in the Pathogenesis of Atherosclerosis
by: Subhapradha Rangarajan, et al.
Published: (2022-11-01) -
Mechanisms and Consequences of Defective Efferocytosis in Atherosclerosis
by: Arif Yurdagul, et al.
Published: (2018-01-01) -
Resolvin D1 and Resolvin E1 Promote the Resolution of Allergic Airway Inflammation Via Shared and Distinct Molecular Counter-Regulatory Pathways
by: Bruce D Levy
Published: (2012-12-01) -
A 17-kDa Fragment of Lactoferrin Associates With the Termination of Inflammation and Peptides Within Promote Resolution
by: Aviv Lutaty, et al.
Published: (2018-03-01) -
Phagocytosis of Apoptotic Cells in Resolution of Inflammation
by: Ioannis Kourtzelis, et al.
Published: (2020-03-01)